Anti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer

Cyclo-oxygenase-2 and vascular endothelial growth factor expression in colorectal cancer patients

The Effect of Primary Tumor Site on Survival in Metastatic Colorectal Cancer Patients and their Relation to KRAS and Biological Therapy

Management of Liver Metastasis of Colorectal Cancer

Study Of Biomarkers In Colorectal Cancer Invasion To The Liver

Study of AnnexinA3 and Platelet Derived Endothelial Cell Growth Factor (Thymidine Phosphorylase) in Colorectal cancer

Phase II Randomized Trial of Biweekly Bevacizumab, Capecitabine, Oxaliplatin and Irinotecan (BEV- CAPEOXIRI) Versus Triweekly Bevacizumab, Capecitabine and Oxaliplatin (BEV- CAPEOX) in Metastatic Colon Carcinoma

Does the number of metastatic organ involvement affect the response to irinotecan-based chemotherapy in patients with metastatic colorectal

Resection versus Radiofrequency Thermal Ablation of Colorectal Liver Metastasis: A Retrospective Comparative Study

Reporting of lymphovascular invasion and non-nodal tumor deposits as prognostic risk factors in colorectal cancer patients